Skip to main content
FinSpry Logo
FinSpry
XTLB logo
XTLB
(NASDAQ)
XTL Biopharmaceuticals Ltd.
$2.34-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

XTL Biopharmaceuticals (XTLB) Stock Price & Financial Analysis

XTL Biopharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.34 - $2.45
52-Week High$5.64
52-Week Low$0.70
Open$2.39
Volume9.82K
Average Volume (3M)9.82K
Market Cap4.12M
Shares Outstanding1.76M
Price to Sales (P/S)9.13
Price to Book (P/B)0.76
EV/EBITDA-3.39
Revenue (TTM)451.00K
Net Income (TTM)-1.03M
EPS (TTM)$-0.58
Profit Margin-227.72%
Operating Margin-481.60%
Return on Equity (ROE)-18.90%
Debt to Equity0.03
50-Day MA$3.02
200-Day MA$1.86
52-Week Change108.00%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About XTL Biopharmaceuticals

What is the current stock price for XTLB?

As of the latest trading session, XTLB stock trades at $2.34. The 52-week range is $0.70–$5.64, with a day range of $2.34–$2.45.

What is the P/E ratio for XTLB?

The P/E ratio (Price-to-Earnings) for XTLB is shown in the Key Statistics section. This valuation metric helps compare XTL Biopharmaceuticals Ltd. to industry peers.

Does XTLB pay dividends?

XTL Biopharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for XTLB?

Analyst ratings and recommendations for XTLB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of XTLB?

XTL Biopharmaceuticals's market capitalization is $4.1M, classifying it as a micro-cap company. XTL Biopharmaceuticals operates in the Healthcare sector within the Biotechnology industry.